Trials / Conditions / JAK Inhibitor
JAK Inhibitor
4 registered clinical trials studyying JAK Inhibitor — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | SHR0302 Combined With PD-1/PD-L1 Inhibition for Treatment naïve or Acquired Resistant to Immunology NSCLC NCT06925048 | Chunxia Su | Phase 2 |
| Enrolling By Invitation | A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous NCT06999941 | Xi Tan | — |
| Unknown | Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inade NCT05090410 | Atsushi Kawakami | Phase 3 |
| Unknown | Discontinuation of Methotrexate in Rheumatoid Arthritis Patients Achieving Clinical Remission by Treatment Wit NCT05121298 | Atsushi Kawakami | Phase 3 |